Evidence map›Paper›PMID 40604517›Full record

ArticleBMC pregnancy and childbirth2025

Global, regional, and national burden, trends, and inequality analysis of maternal hypertensive disorders (MHD) from 1990 to 2021, and predictions to 2046.

Junde Zhao, Ruiting Gong, Xiaohui Sui, Zuocheng Wang, Xiaotao Bian, Yiider Tseng

Abstract read
In one paragraph

Article in BMC pregnancy and childbirth, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. [Costs of pharmacological treatment in hypertension and type 2 diabetes mellitus].Revista medica del Instituto Mexicano del Seguro Social · 2026
    Observational
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Junde Zhao *Shandong University of Traditional Chinese Medicine, Jinan, 250335, Shandong, China.
Ruiting Gong *Obstetrics and Gynecology Department, The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, 250001, China.
Xiaohui SuiShandong University of Traditional Chinese Medicine, Jinan, 250335, Shandong, China.
Zuocheng WangAustralian National University Research School of Biology, Canberra, 2601, Australia.
Xiaotao BianDepartment of Pathology, Dongcheng District, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, 17 Qihelou Street, Beijing, 100006, China.
Yiider TsengShandong University of Traditional Chinese Medicine, Jinan, 250335, Shandong, China. ytseng@sdutcm.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMaternal hypertensive disorders (MHD) are a leading cause of maternal and fetal mortality, with profound short- and long-term public health impacts. MHD epidemiology remains poorly controlled, and the incidence rate has shown an increase over the past few decades. Therefore, a comprehensive assessment of global burden and prevalence inequalities holds considerable significance for optimizing public health strategies.

methodsThe global burden and epidemic trend of MHD from 1990 to 2021 were investigated, and the incidence, prevalence, mortality, and disability-adjusted life years (DALYs) were examined utilizing the Global Burden of Disease (GBD). The trends were stratified by age and socio-demographic index (SDI), and further analysis was performed to delve into the correlation between SDI and incidence, prevalence, mortality, and DALYs. Additionally, a Bayesian Age-Period Cohort (BAPC) model was constructed to predict the burden of disease in MHD from 2022 to 2046.

resultsThe DALYs induced by MHD decreased significantly from 3.48 million (95% UI, 3.09-3.87 million) in 1990 to 2.47 million (95% UI, 2.08-2.96 million) in 2021, involving an Excess Annual Percentage Change (EAPC) of -2.10. Both the age-standardized DALYs rate (ASDR, AAPC = -2.11) and the age-standardized incidence rate (ASIR, AAPC = -0.60) exhibited evident decreasing trends. The ASDRs of all the age-stratified subgroups decreased as well. Notably, the largest declines were observed in the 20-24 age group with an EAPC of -2.39 (95% UI: -2.56, -2.23). The ASIR exhibited an obvious negative correlation with SDI, and the inequality tended to shrink. Projections for 2046 indicate that global ASDR and ASIR are expected to sustain their downward trajectory. Globally, ASDR in MHD linked to iron deficiency decreased significantly (EAPC = -2.03), with High-middle SDI countries experiencing particularly steep reductions (EAPC = -4.25).

conclusionsThis study performed a comprehensive analysis of the global burden of MHD and observed regional and national inequalities. The investigation also identified a correlation between MHD and SDI, and most regions exhibited an overall declining trend in disease burden. However, further investigations should still be conducted to assist the establishment of public health strategies for MHD prevention.

Indexed as

Global Burden of DiseaseHealth Status DisparitiesHypertension, Pregnancy-InducedAdultBayes TheoremCost of IllnessDisability-Adjusted Life YearsFemaleGlobal HealthHumansIncidenceMiddle AgedPregnancyPrevalenceQuality-Adjusted Life YearsSocioeconomic FactorsDisability-adjusted life yearsGlobal burden of diseaseHypertensionIncidenceMaternal Hypertensive Disorders

Identifiers

PMID40604517
PMCPMC12220113

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.